Alternate Day Buprenorphine Administration, Phase XI - 16



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:25 - 51
Updated:5/7/2016

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Alternate Day Buprenorphine Administration, Phase XI

The purpose of this study is to evaluate open buprenorphine dosing with dose choice after
open exposure.


Please contact site for information.
We found this trial at
1
site
Treatment Research Center
Burlington, Vermont 05401
?
mi
from
Burlington, VT
Click here to add this to my saved trials